Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/1982
03/31/1982EP0048283A1 Virus-inhibiting substance and process for preparing the same
03/30/1982US4322404 Process for the production of new mutants of herpes simplex virus type 1 and type 2
03/30/1982US4322403 Method for the preparation of an immune globulin solution suitable for intravenous use
03/30/1982US4322275 Fractionation of protein mixtures
03/30/1982CA1120856A1 Living virus culture vaccine against canine distemper and method of preparing same
03/30/1982CA1120855A1 Chagas vaccine and process for its manufacture, killed trypanosoma and their use for the manufacture of immunologically active cell constituents
03/24/1982EP0048202A2 Method of preparing a mycoplasma-free hepatoma cell line
03/24/1982EP0048201A2 Herpes simplex type I fraction vaccine and process for its preparation
03/24/1982EP0048194A2 Lyophilization process
03/24/1982EP0047802A2 Method for producing pertussis toxoid
03/23/1982US4321192 Fractionation of protein mixtures by salt addition followed by dialysis treatment
03/17/1982EP0047662A2 Coccidiosis vaccines
03/17/1982EP0047485A2 Process for the propagation of protozoal and their use
03/17/1982EP0047480A2 Formation of an immunosome exclusively made of viral antigens reconstituted on an artificial membrane
03/16/1982US4320115 Rabies virus vaccine
03/16/1982CA1119953A1 Method and apparatus for making novel particulate compositions
03/10/1982EP0046909A2 Pharmaceutical composition
03/10/1982EP0046790A1 The use of eucaryotic promoter sequences in the production of proteinaceous materials
03/09/1982US4318903 Live influenza virus vaccine and the preparation thereof
03/09/1982US4318902 B-propiolactone
03/02/1982US4317811 Herpes simplex type 1 subunit vaccine
03/02/1982US4317771 Muramyldipeptide derivatives
03/02/1982CA1119095A1 Heterovaccine against the trichomonas syndrome and process for its preparation
02/1982
02/16/1982US4315914 Pharmaceutical compositions useful as cellular immunopotentiator and antitumor agent and process for production thereof
02/16/1982US4315913 Immunologically active dipeptidyl 2-amino-1,2-dideoxy-D-glucose derivatives and methods of preparation
02/16/1982CA1118348A1 Solidified pharmaceutical composition comprising cell wall skeleton
02/16/1982CA1118347A1 Induction of immunological tolerance
02/16/1982CA1118346A1 Process for production of protein bound gel useful in radioimmunoassay columns
02/16/1982CA1118345A1 F(ab')2 immunoglobulin fragments for assay of antigen
02/16/1982CA1118344A1 Bridging the sulphur atom of antigen, antibody or fragments to a substrate
02/09/1982US4314993 Immunogenic E. coli ST enterotoxin derivatives and compositions containing them
02/09/1982US4314992 Infecting snails, cesium-137 gamma rays
02/09/1982CA1117882A1 Process for the preparation of a novel biological product and product thus prepared
02/09/1982CA1117866A1 Haemophilus influenzae vaccine
02/03/1982EP0044920A2 Veterinary rabies vaccine
02/02/1982US4313936 Antitumour agent
02/02/1982US4313871 Antigen for early pregnancy test and contraceptive vaccine
02/02/1982CA1117417A1 Stabilized immune serum globulin
02/02/1982CA1117416A1 Fowl cholera vaccine
01/1982
01/27/1982EP0044793A2 High titer production of hepatitis A virus
01/27/1982EP0044722A1 Human hybridomas, precursors and products
01/27/1982EP0044710A1 Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom
01/27/1982EP0044441A1 Monoclonal antibodies to drugs, methods for their production and somatic cell hybridomas secreting them
01/26/1982US4312949 Method for the preparation of a gamma globulin solution suitable for intravenous use
01/26/1982US4312947 Process for the preparation of a vaccine against panleucopenia of the cat
01/26/1982CA1117010A1 Vaccine for active immunization containing hepatitis b surface and/or e-antigens
01/26/1982CA1117009A1 Fc fragment of immunoglobulin bound to a carrier
01/21/1982WO1982000205A1 Non-a,non-b hepatitis assay and vaccine
01/20/1982EP0044188A2 Synthesis of tumor antigenic determinant
01/20/1982EP0044167A2 Antibody targeted cytotoxic agent
01/20/1982EP0043847A1 Highly attenuated varicella virus vaccine and production thereof
01/19/1982US4311797 Anucleated live E. coli vaccine
01/19/1982US4311688 Composition and method for cancer detection in humans
01/19/1982US4311686 Methodology for the immunodiagnosis of multiple sclerosis and/or malignant diseases from blood sample analysis
01/13/1982EP0043718A2 Improvements in or relating to cell lines
01/13/1982EP0043608A1 Hemolytic method for the kinetic determination of antistreptolysin O antibodies in blood or serum samples, using oxidised SO
01/12/1982US4310637 Blend with a halogenated polyolefin and an acrylonitrile-diene-styrene terpolymer
01/12/1982US4310550 Lipid amines formulated with fat or lipid emulsions as vaccine adjuvants
01/12/1982US4310514 Vaccines
01/12/1982US4310456 Vaccines as contraceptives
01/12/1982US4310455 Antigen for early pregnancy test and contraceptive vaccine
01/12/1982CA1116078A1 Heparin to stabilize platelet factor 4 protein
01/06/1982EP0043272A1 Production of viral antigens
01/05/1982US4309416 Vaccines from taxonomically similar organisms
01/05/1982US4309339 Isolated from human sera, used for preparation of antisera for medical diagnosis
12/1981
12/30/1981EP0042560A2 A process for producing and obtaining anaphylatoxin- and cocytotaxin-containing leucotaxine preparations and of anaphylatoxin and cocytotaxin proteins in molecularly homogeneous, biologically active form
12/30/1981EP0042428A1 Purified human prostate antigen
12/29/1981US4308376 Synthesis of 2-amino-2-deoxyglycoses and 2-amino-2-deoxyglycosides from glycals
12/29/1981US4308254 Material able to fix reversibly biologial macromolecules, its preparation and its application
12/29/1981CA1115210A1 Pneumococcal vaccine
12/24/1981WO1981003663A1 Human hepatoma derived cell line,process for preparation thereof,and uses therefor
12/23/1981EP0042064A2 Modulators of the immune system
12/22/1981US4307191 Propagation of babesia parasites
12/22/1981US4307080 Meningitis vaccine
12/22/1981CA1114812A1 Hapten polysaccharide conjugates
12/22/1981CA1114772A1 Purification of glycoproteins and immunization therewith
12/16/1981EP0041897A2 Polysaccharide antigen from streptococcus and vaccines
12/16/1981EP0041896A1 Immunologically active dipeptidyl 2-amino-1,2-dideoxy-D-glucose derivatives and methods of preparation
12/16/1981EP0041880A1 Process for isolating viral glycoproteic antigens, and its use in the preparation of vaccines
12/16/1981EP0041767A2 Improved vectors and methods for making such vectors and for expressing cloned genes
12/15/1981CA1114294A1 Herpes subunit vaccine
12/15/1981CA1114292A1 Method and compositions for the control of coccidiosis in poultry
12/09/1981EP0041350A2 Method and apparatus for on-line filtration removal of macromolecules from a physiological fluid
12/08/1981CA1113861A1 Stabilizer for polysaccharides
12/08/1981CA1113860A1 Live newcastle disease virus vaccine
12/01/1981US4303645 Modified living canine parvovirus vaccine
12/01/1981US4303644 Feline infectious peritonitis virus vaccines
12/01/1981US4303638 Particles coated with gangliosides, toxin
12/01/1981CA1113394A1 Anti-hemocytic serum and a method for the preparation thereof
12/01/1981CA1113389A1 ANTIGEN .beta..H.C.G. CLEAVED AND ALKYLATED
11/1981
11/26/1981WO1981003279A1 Modulators of the immune system
11/25/1981EP0040572A1 Process for obtaining toxoplasma preparations for the toxoplasmosis diagnosis, and preparations so obtained
11/25/1981EP0040506A2 Reactive polymer and process for the preparation thereof
11/25/1981EP0040397A1 Process for the preparation of blood plasma fractions
11/24/1981US4302444 Vaccines for immunizing egg-laying birds against Egg Drop disease, preparation of said vaccines, and method of use of said vaccines
11/24/1981US4302386 Hormones linked to a group causing immune response
11/24/1981US4302385 Placenta-specific tissue protein PP10
11/24/1981US4302384 Ion exchanging
11/17/1981US4301250 Method of producing hepatitis B surface antigen
11/17/1981US4301249 High titer production of hepatitis A virus